Global Biologics Contract Development Market Size Study & Forecast, By Source (Microbial, Mammalian, Others), by Product Service (Cell Line Development, Process Development, Others), by Disease Indication (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Others) and Regional Analysis, 2023-2030
Global Biologics Contract Development Market is valued at approximately USD 6.08 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 10.5% over the forecast period 2023-2030. Biologics contract development refers to the outsourcing of development and manufacturing services for biologic drugs or therapies to contract development and manufacturing organizations (CDMOs) or contract research organizations (CROs). Biologics are complex molecules derived from living organisms, including proteins, antibodies, vaccines, and gene therapies. The rising adoption of advanced technology for biological production is acting as a catalyzing factor for market growth. Furthermore, increased drug development methods by pharmaceutical companies, increased drug approval rates by the Food and Drug Administration, increased use of targeted pharmacological therapies, and increased desire for personalized medication are some of the factors resulting in the increase in market growth.
In addition, the surging prevalence of diseases such as neurological illnesses, gynecological disorders, cancer, ophthalmic disorders, and cardiovascular disorders are contributing to the market development across the globe. According to World Health Organization in 2022, cancer is one of the main causes of death worldwide, accounting for over 10 million deaths in 2020. According to Cancer Tomorrow predictions in 2020, approximately 19.3 million cancer cases were reported in 2020, with this figure anticipated to climb to 30.2 million by 2040. In such circumstances, healthcare CDMOs play an important role in patient care because many biopharma companies aspire to develop novel medicines or first-in-class products for illness treatment. Furthermore, an increase in the adoption of advanced technologies for biologic development, a favorable environment for clinical trials in developing countries, an increase in the number of collaborations, contracts, and mergers with local players to develop advanced biologic products, and an increase in the development of greater manufacturing flexibility in the biopharmaceutical sector is expected to provide lucrative opportunities for market growth over the forecasting period. However, the high cost of biologics production processes, as well as a lack of understanding about the usage of these products, limit the growth of the biologics contract development industry.
The key regions considered for the Global Biologics Contract Development Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is expected to lead the market in 2021. Strategic collaborations and acquisitions, as well as growing demand for specialized testing services, are driving the market. The growth of contract development organizations (CDOs) can be attributed mostly to the region's increased clinical trial and outsourcing activity. Furthermore, the high prevalence of chronic diseases is substantial fostering the demand for clinical studies in this region. These factors drive market expansion. Asia Pacific is expected to be the fastest growing region during the forecast period, because of different regulatory organization adjustments to update clinical trial evaluation standards based on global needs, biotechnology businesses are investing in the Asia Pacific region.
Major market players included in this report are:
WuXi Biologics
Abzena Ltd
Fujifilm Diosynth Biotechnologies
KBI Biopharma, Inc.
AGC Biologics
Thermo Fisher Scientific Inc.
Curia Global, Inc.
Genscript
Bionova Scientific, Inc.
BioXcellence (Boehringer Ingelheim Biopharmaceuticals GmbH)
Recent Developments in the Market:
In September 2020, Almac Group recently announced the beginning of a contract for testing and development services for biologics. The development and testing of new biologic products will benefit from this expansion.
In February 2020, Lake Pharma In., Inc. has announced the debut of combined chemistry and biologics services, for faster antibody-drug conjugates development solutions for the pharmaceutical and biotechnology sectors.
Global Biologics Contract Development Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Source, Product Services, Disease Indication, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Source:
Microbial
Mammalian
Others
By Product Service:
Cell Line Development
Process Development
Others
By Disease Indication:
Oncology
Immunological Disorders
Cardiovascular Disorders
Hematological Disorders
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
In addition, the surging prevalence of diseases such as neurological illnesses, gynecological disorders, cancer, ophthalmic disorders, and cardiovascular disorders are contributing to the market development across the globe. According to World Health Organization in 2022, cancer is one of the main causes of death worldwide, accounting for over 10 million deaths in 2020. According to Cancer Tomorrow predictions in 2020, approximately 19.3 million cancer cases were reported in 2020, with this figure anticipated to climb to 30.2 million by 2040. In such circumstances, healthcare CDMOs play an important role in patient care because many biopharma companies aspire to develop novel medicines or first-in-class products for illness treatment. Furthermore, an increase in the adoption of advanced technologies for biologic development, a favorable environment for clinical trials in developing countries, an increase in the number of collaborations, contracts, and mergers with local players to develop advanced biologic products, and an increase in the development of greater manufacturing flexibility in the biopharmaceutical sector is expected to provide lucrative opportunities for market growth over the forecasting period. However, the high cost of biologics production processes, as well as a lack of understanding about the usage of these products, limit the growth of the biologics contract development industry.
The key regions considered for the Global Biologics Contract Development Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is expected to lead the market in 2021. Strategic collaborations and acquisitions, as well as growing demand for specialized testing services, are driving the market. The growth of contract development organizations (CDOs) can be attributed mostly to the region's increased clinical trial and outsourcing activity. Furthermore, the high prevalence of chronic diseases is substantial fostering the demand for clinical studies in this region. These factors drive market expansion. Asia Pacific is expected to be the fastest growing region during the forecast period, because of different regulatory organization adjustments to update clinical trial evaluation standards based on global needs, biotechnology businesses are investing in the Asia Pacific region.
Major market players included in this report are:
WuXi Biologics
Abzena Ltd
Fujifilm Diosynth Biotechnologies
KBI Biopharma, Inc.
AGC Biologics
Thermo Fisher Scientific Inc.
Curia Global, Inc.
Genscript
Bionova Scientific, Inc.
BioXcellence (Boehringer Ingelheim Biopharmaceuticals GmbH)
Recent Developments in the Market:
In September 2020, Almac Group recently announced the beginning of a contract for testing and development services for biologics. The development and testing of new biologic products will benefit from this expansion.
In February 2020, Lake Pharma In., Inc. has announced the debut of combined chemistry and biologics services, for faster antibody-drug conjugates development solutions for the pharmaceutical and biotechnology sectors.
Global Biologics Contract Development Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Source, Product Services, Disease Indication, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Source:
Microbial
Mammalian
Others
By Product Service:
Cell Line Development
Process Development
Others
By Disease Indication:
Oncology
Immunological Disorders
Cardiovascular Disorders
Hematological Disorders
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Biologics Contract Development Market, by Region, 2020-2030 (USD Billion)
1.2.2. Biologics Contract Development Market, by Source, 2020-2030 (USD Billion)
1.2.3. Biologics Contract Development Market, by Product Service, 2020-2030 (USD Billion)
1.2.4. Biologics Contract Development Market, by Disease Indication, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET DYNAMICS
3.1. Biologics Contract Development Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of various target diseases
3.1.1.2. Increased drug development methods by pharmaceutical companies population
3.1.1.3. Increased inclination for personalised medication by consumers
3.1.2. Market Challenges
3.1.2.1. High Cost of biologics production processes
3.1.3. Market Opportunities
3.1.3.1. Increase in the adoption of advanced technologies for biological development
3.1.3.2. Increase in the development of greater manufacturing flexibility in the biopharmaceutical sector
CHAPTER 4. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET, BY SOURCE
5.1. Market Snapshot
5.2. Global Biologics Contract Development Market by Source, Performance - Potential Analysis
5.3. Global Biologics Contract Development Market Estimates & Forecasts by Source 2020-2030 (USD Billion)
5.4. Biologics Contract Development Market, Sub Segment Analysis
5.4.1. Microbial
5.4.2. Mammalian
5.4.3. Others
CHAPTER 6. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET, BY PRODUCT SERVICE
6.1. Market Snapshot
6.2. Global Biologics Contract Development Market by Product Service, Performance - Potential Analysis
6.3. Global Biologics Contract Development Market Estimates & Forecasts by Product Service 2020-2030 (USD Billion)
6.4. Biologics Contract Development Market, Sub Segment Analysis
6.4.1. Cell Line Development
6.4.2. Process Development
6.4.3. Others
CHAPTER 7. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET, BY DISEASE INDICATION
7.1. Market Snapshot
7.2. Global Biologics Contract Development Market by Disease Indication, Performance - Potential Analysis
7.3. Global Biologics Contract Development Market Estimates & Forecasts by Disease Indication 2020-2030 (USD Billion)
7.4. Biologics Contract Development Market, Sub Segment Analysis
7.4.1. Oncology
7.4.2. Immunological Disorders
7.4.3. Cardiovascular Disorders
7.4.4. Hematological Disorders
7.4.5. Others
CHAPTER 8. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Biologics Contract Development Market, Regional Market Snapshot
8.4. North America Biologics Contract Development Market
8.4.1. U.S. Biologics Contract Development Market
8.4.1.1. Source breakdown estimates & forecasts, 2020-2030
8.4.1.2. Product Service breakdown estimates & forecasts, 2020-2030
8.4.1.3. Disease Indication breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Biologics Contract Development Market
8.5. Europe Biologics Contract Development Market Snapshot
8.5.1. U.K. Biologics Contract Development Market
8.5.2. Germany Biologics Contract Development Market
8.5.3. France Biologics Contract Development Market
8.5.4. Spain Biologics Contract Development Market
8.5.5. Italy Biologics Contract Development Market
8.5.6. Rest of Europe Biologics Contract Development Market
8.6. Asia-Pacific Biologics Contract Development Market Snapshot
8.6.1. China Biologics Contract Development Market
8.6.2. India Biologics Contract Development Market
8.6.3. Japan Biologics Contract Development Market
8.6.4. Australia Biologics Contract Development Market
8.6.5. South Korea Biologics Contract Development Market
8.6.6. Rest of Asia Pacific Biologics Contract Development Market
8.7. Latin America Biologics Contract Development Market Snapshot
8.7.1. Brazil Biologics Contract Development Market
8.7.2. Mexico Biologics Contract Development Market
8.8. Middle East & Africa Biologics Contract Development Market
8.8.1. Saudi Arabia Biologics Contract Development Market
8.8.2. South Africa Biologics Contract Development Market
8.8.3. Rest of Middle East & Africa Biologics Contract Development Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. WuXi Biologics
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Abzena Ltd
9.3.3. Fujifilm Diosynth Biotechnologies
9.3.4. KBI Biopharma, Inc.
9.3.5. AGC Biologics
9.3.6. Thermo Fisher Scientific Inc.
9.3.7. Curia Global, Inc.
9.3.8. Genscript
9.3.9. Bionova Scientific, Inc.
9.3.10. BioXcellence (Boehringer Ingelheim Biopharmaceuticals GmbH)
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Biologics Contract Development Market, by Region, 2020-2030 (USD Billion)
1.2.2. Biologics Contract Development Market, by Source, 2020-2030 (USD Billion)
1.2.3. Biologics Contract Development Market, by Product Service, 2020-2030 (USD Billion)
1.2.4. Biologics Contract Development Market, by Disease Indication, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET DYNAMICS
3.1. Biologics Contract Development Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of various target diseases
3.1.1.2. Increased drug development methods by pharmaceutical companies population
3.1.1.3. Increased inclination for personalised medication by consumers
3.1.2. Market Challenges
3.1.2.1. High Cost of biologics production processes
3.1.3. Market Opportunities
3.1.3.1. Increase in the adoption of advanced technologies for biological development
3.1.3.2. Increase in the development of greater manufacturing flexibility in the biopharmaceutical sector
CHAPTER 4. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET, BY SOURCE
5.1. Market Snapshot
5.2. Global Biologics Contract Development Market by Source, Performance - Potential Analysis
5.3. Global Biologics Contract Development Market Estimates & Forecasts by Source 2020-2030 (USD Billion)
5.4. Biologics Contract Development Market, Sub Segment Analysis
5.4.1. Microbial
5.4.2. Mammalian
5.4.3. Others
CHAPTER 6. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET, BY PRODUCT SERVICE
6.1. Market Snapshot
6.2. Global Biologics Contract Development Market by Product Service, Performance - Potential Analysis
6.3. Global Biologics Contract Development Market Estimates & Forecasts by Product Service 2020-2030 (USD Billion)
6.4. Biologics Contract Development Market, Sub Segment Analysis
6.4.1. Cell Line Development
6.4.2. Process Development
6.4.3. Others
CHAPTER 7. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET, BY DISEASE INDICATION
7.1. Market Snapshot
7.2. Global Biologics Contract Development Market by Disease Indication, Performance - Potential Analysis
7.3. Global Biologics Contract Development Market Estimates & Forecasts by Disease Indication 2020-2030 (USD Billion)
7.4. Biologics Contract Development Market, Sub Segment Analysis
7.4.1. Oncology
7.4.2. Immunological Disorders
7.4.3. Cardiovascular Disorders
7.4.4. Hematological Disorders
7.4.5. Others
CHAPTER 8. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Biologics Contract Development Market, Regional Market Snapshot
8.4. North America Biologics Contract Development Market
8.4.1. U.S. Biologics Contract Development Market
8.4.1.1. Source breakdown estimates & forecasts, 2020-2030
8.4.1.2. Product Service breakdown estimates & forecasts, 2020-2030
8.4.1.3. Disease Indication breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Biologics Contract Development Market
8.5. Europe Biologics Contract Development Market Snapshot
8.5.1. U.K. Biologics Contract Development Market
8.5.2. Germany Biologics Contract Development Market
8.5.3. France Biologics Contract Development Market
8.5.4. Spain Biologics Contract Development Market
8.5.5. Italy Biologics Contract Development Market
8.5.6. Rest of Europe Biologics Contract Development Market
8.6. Asia-Pacific Biologics Contract Development Market Snapshot
8.6.1. China Biologics Contract Development Market
8.6.2. India Biologics Contract Development Market
8.6.3. Japan Biologics Contract Development Market
8.6.4. Australia Biologics Contract Development Market
8.6.5. South Korea Biologics Contract Development Market
8.6.6. Rest of Asia Pacific Biologics Contract Development Market
8.7. Latin America Biologics Contract Development Market Snapshot
8.7.1. Brazil Biologics Contract Development Market
8.7.2. Mexico Biologics Contract Development Market
8.8. Middle East & Africa Biologics Contract Development Market
8.8.1. Saudi Arabia Biologics Contract Development Market
8.8.2. South Africa Biologics Contract Development Market
8.8.3. Rest of Middle East & Africa Biologics Contract Development Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. WuXi Biologics
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Abzena Ltd
9.3.3. Fujifilm Diosynth Biotechnologies
9.3.4. KBI Biopharma, Inc.
9.3.5. AGC Biologics
9.3.6. Thermo Fisher Scientific Inc.
9.3.7. Curia Global, Inc.
9.3.8. Genscript
9.3.9. Bionova Scientific, Inc.
9.3.10. BioXcellence (Boehringer Ingelheim Biopharmaceuticals GmbH)
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Biologics Contract Development Market, report scope
TABLE 2. Global Biologics Contract Development Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Biologics Contract Development Market estimates & forecasts by Source 2020-2030 (USD Billion)
TABLE 4. Global Biologics Contract Development Market estimates & forecasts by Product Service 2020-2030 (USD Billion)
TABLE 5. Global Biologics Contract Development Market estimates & forecasts by Disease Indication 2020-2030 (USD Billion)
TABLE 6. Global Biologics Contract Development Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Biologics Contract Development Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Biologics Contract Development Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Biologics Contract Development Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Biologics Contract Development Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Biologics Contract Development Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Biologics Contract Development Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Biologics Contract Development Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Biologics Contract Development Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Biologics Contract Development Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Biologics Contract Development Market
TABLE 71. List of primary sources, used in the study of global Biologics Contract Development Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Biologics Contract Development Market, report scope
TABLE 2. Global Biologics Contract Development Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Biologics Contract Development Market estimates & forecasts by Source 2020-2030 (USD Billion)
TABLE 4. Global Biologics Contract Development Market estimates & forecasts by Product Service 2020-2030 (USD Billion)
TABLE 5. Global Biologics Contract Development Market estimates & forecasts by Disease Indication 2020-2030 (USD Billion)
TABLE 6. Global Biologics Contract Development Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Biologics Contract Development Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Biologics Contract Development Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Biologics Contract Development Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Biologics Contract Development Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Biologics Contract Development Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Biologics Contract Development Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Biologics Contract Development Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Biologics Contract Development Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Biologics Contract Development Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Biologics Contract Development Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Biologics Contract Development Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Biologics Contract Development Market
TABLE 71. List of primary sources, used in the study of global Biologics Contract Development Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Biologics Contract Development Market, research methodology
FIG 2. Global Biologics Contract Development Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Biologics Contract Development Market, key trends 2022
FIG 5. Global Biologics Contract Development Market, growth prospects 2023-2030
FIG 6. Global Biologics Contract Development Market, porters 5 force model
FIG 7. Global Biologics Contract Development Market, pest analysis
FIG 8. Global Biologics Contract Development Market, value chain analysis
FIG 9. Global Biologics Contract Development Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Biologics Contract Development Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Biologics Contract Development Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Biologics Contract Development Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Biologics Contract Development Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Biologics Contract Development Market, regional snapshot 2020 & 2030
FIG 15. North America Biologics Contract Development Market 2020 & 2030 (USD Billion)
FIG 16. Europe Biologics Contract Development Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Biologics Contract Development Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Biologics Contract Development Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Biologics Contract Development Market 2020 & 2030 (USD Billion)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Biologics Contract Development Market, research methodology
FIG 2. Global Biologics Contract Development Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Biologics Contract Development Market, key trends 2022
FIG 5. Global Biologics Contract Development Market, growth prospects 2023-2030
FIG 6. Global Biologics Contract Development Market, porters 5 force model
FIG 7. Global Biologics Contract Development Market, pest analysis
FIG 8. Global Biologics Contract Development Market, value chain analysis
FIG 9. Global Biologics Contract Development Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Biologics Contract Development Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Biologics Contract Development Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Biologics Contract Development Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Biologics Contract Development Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Biologics Contract Development Market, regional snapshot 2020 & 2030
FIG 15. North America Biologics Contract Development Market 2020 & 2030 (USD Billion)
FIG 16. Europe Biologics Contract Development Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Biologics Contract Development Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Biologics Contract Development Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Biologics Contract Development Market 2020 & 2030 (USD Billion)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
